BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 9284829)

  • 21. Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders.
    Knecht H; Bachmann E; Brousset P; Rothenberger S; Einsele H; Lestou VS; Delsol G; Bachmann F; Ambros PF; Odermatt BF
    Oncogene; 1995 Feb; 10(3):523-8. PubMed ID: 7845677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular genetic analysis demonstrates that multiple posttransplantation lymphoproliferative disorders occurring in one anatomic site in a single patient represent distinct primary lymphoid neoplasms.
    Chadburn A; Cesarman E; Liu YF; Addonizio L; Hsu D; Michler RE; Knowles DM
    Cancer; 1995 Jun; 75(11):2747-56. PubMed ID: 7743481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of Epstein-Barr viral sequences and EBV LMP1 oncogene deletions in Burkitt's lymphoma from Pakistan: epidemiological correlations.
    Mansoor A; Stevenson MS; Li RZ; Frekko K; Weiss W; Ahmad M; Khan AH; Mushtaq S; Saleem M; Raffeld M; Kingma DW; Jaffe ES
    Hum Pathol; 1997 Mar; 28(3):283-8. PubMed ID: 9042791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma.
    Knecht H; Martius F; Bachmann E; Hoffman T; Zimmermann DR; Rothenberger S; Sandvej K; Wegmann W; Hurwitz N; Odermatt BF
    Leukemia; 1995 Mar; 9(3):458-65. PubMed ID: 7885044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients.
    Liebowitz D
    N Engl J Med; 1998 May; 338(20):1413-21. PubMed ID: 9580648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of the Epstein-Barr virus infection and 30 bp-deleted LMP1 gene among 4 histologic types of nasopharyngeal carcinoma].
    Zhang M; Zong YS; He JH; Zhong BL; Lin SX; Liang YJ
    Zhonghua Bing Li Xue Za Zhi; 2003 Aug; 32(4):342-6. PubMed ID: 14514380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of Epstein-Barr virus strains and LMP1-deletion variants in Portugal.
    Neves M; Marinho-Dias J; Ribeiro J; Esteves M; Maltez E; Baldaque I; Breda E; Monteiro E; Medeiros R; Sousa H
    J Med Virol; 2015 Aug; 87(8):1382-8. PubMed ID: 25879824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.
    Rea D; Fourcade C; Leblond V; Rowe M; Joab I; Edelman L; Bitker MO; Gandjbakhch I; Suberbielle C; Farcet JP
    Transplantation; 1994 Aug; 58(3):317-24. PubMed ID: 8053055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent expression of the tumor necrosis factor receptor-associated factor 1 in latent membrane protein 1-positive posttransplant lymphoproliferative disease and HIV-associated lymphomas.
    Murray PG; Swinnen LJ; Flavell JR; Ragni MV; Baumforth KR; Toomey SM; Filipovich AH; Lowe D; Schnell CS; Johl J; Gulley M; Young LS; Ambinder RF
    Hum Pathol; 2001 Sep; 32(9):963-9. PubMed ID: 11567226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
    Ohga S; Ishimura M; Yoshimoto G; Miyamoto T; Takada H; Tanaka T; Ohshima K; Ogawa Y; Imadome K; Abe Y; Akashi K; Hara T
    J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequence polymorphisms between latent membrane proteins LMP1 and LMP2A do not correlate in EBV-associated reactive and malignant lympho-proliferations.
    Berger C; Rothenberger S; Bachmann E; McQuain C; Nadal D; Knecht H
    Int J Cancer; 1999 May; 81(3):371-5. PubMed ID: 10209951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in Thais.
    Tiwawech D; Srivatanakul P; Karalak A; Ishida T
    J Clin Virol; 2008 May; 42(1):1-6. PubMed ID: 18180201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural 30 base pair and 69 base pair deletion variants of the LMP1 oncogene do stimulate NF-kappaB-mediated transcription.
    Rothenberger S; Bachmann E; Berger C; McQuain C; Odermatt BF; Knecht H
    Oncogene; 1997 May; 14(17):2123-6. PubMed ID: 9160892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus (EBV)-associated smooth-muscle tumor arising in a post-transplant patient treated successfully for two PT-EBV-associated large-cell lymphomas. Case report.
    Kingma DW; Shad A; Tsokos M; Fest T; Otsuki T; Frekko K; Werner E; Werner A; Magrath I; Raffeld M; Jaffe ES
    Am J Surg Pathol; 1996 Dec; 20(12):1511-9. PubMed ID: 8944045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient origin.
    Chadburn A; Suciu-Foca N; Cesarman E; Reed E; Michler RE; Knowles DM
    Am J Pathol; 1995 Dec; 147(6):1862-70. PubMed ID: 7495309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deletion of Epstein-Barr virus latent membrane protein 1 gene in United States and Brazilian Hodgkin's disease and reactive lymphoid tissue: high frequency of a 30-bp deletion.
    Hayashi K; Chen WG; Chen YY; Bacchi MM; Bacchi CE; Alvarenga M; Abreu ES; Chang KL; Weiss LM
    Hum Pathol; 1997 Dec; 28(12):1408-14. PubMed ID: 9416698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina.
    Chabay P; De Matteo E; Merediz A; Preciado MV
    Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletion variants within the NF-kappaB activation domain of the LMP1 oncogene in acquired immunodeficiency syndrome-related large cell lymphomas, in prelymphomas and atypical lymphoproliferations.
    Berger C; Brousset P; McQuain C; Knecht H
    Leuk Lymphoma; 1997 Jul; 26(3-4):239-50. PubMed ID: 9322886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus (EBV) variant with a 30-bp deletion at the carboxyl terminus (amino acids 346-355) of latent membrane protein-1 (LMP1) gene is able to transform cells and evade immune surveillance.
    Tao Q; Ambinder RF; Swinnen LJ
    Am J Pathol; 1998 May; 152(5):1398-9. PubMed ID: 9588909
    [No Abstract]   [Full Text] [Related]  

  • 40. Epstein-Barr virus strain type and latent membrane protein 1 gene deletions in lymphomas in patients with rheumatic diseases.
    Natkunam Y; Elenitoba-Johnson KS; Kingma DW; Kamel OW
    Arthritis Rheum; 1997 Jun; 40(6):1152-6. PubMed ID: 9182927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.